期刊文献+

SIRT1去乙酰化酶在代谢和抗衰老中的作用机制 被引量:2

在线阅读 下载PDF
导出
作者 何琪杨
出处 《实用老年医学》 CAS 2010年第1期13-16,共4页 Practical Geriatrics
  • 相关文献

参考文献21

  • 1Howitz KT, Bitterman K J, Cohen HY, et al. Small molecule activators of sirtuins extend accharomyces cerevisiae lifespan [ J]. Nature, 2003, 425(6954) : 191-196.
  • 2Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity [ J ]. Nat Rev Mol Cell Biol, 2005, 6(4) : 298-305.
  • 3Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGClalpha and SIRT1 [ J ]. Nature, 2005, 434(7029) : 115-118.
  • 4Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 [ J]. Cell, 2006, 127(6): 1109-1122.
  • 5Moynihan KA, Grimm AA, Plueger MM, et al. Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice [ J ]. Cell Metab, 2005, 2(2) : 105-117.
  • 6Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B [ J]. Cell Metab, 2007, 6(4) : 307-319.
  • 7Erion DM, Yonemitsu S, Nie Y, et al. Sirtl knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats[J ]. ProcNatl Acad Sci U S A, 2009, 106 (27) : 11288-11293.
  • 8Pieard F, Kurtev M, Chung N, et al. Sirtl promotes fat mobilization in white adipocytes by repressing PPAR-gamma [ J ].Nature, 2004, 429 ( 6993 ): 771-776.
  • 9Pfluger PT, Herranz D, Velasco-Miguel S, et al. Sirtl protects against high-fat diet-induced metabolic damage [ J]. Proc Natl Acad Sci U S A, 2008, 105(28) : 9793-9798.
  • 10You M, Hang X, Ajmo JM, et al. Involvement of mammalian sirtuin 1 in the action of ethanol in the liver [ J ]. Am J Physiol Gastrointest Liver Physiol, 2008, 294(4) : G892-G898.

同被引文献78

  • 1金红芳,杜军保,唐朝枢.气体信号分子在心血管疾病发病中的意义[J].中国医学科学院学报,2005,27(4):518-524. 被引量:18
  • 2Hoy D, Brooks P, Blyth F, et al. The Epidmn.idogy of low back pain[J]. Best Pratt Res Clin Rheutr tol, 2010, 24(6) 769-781.
  • 3Namart2is D, Karppinen J, Mok F, et al. A population-based study of juvenile disc degeneration and its association with overweight and obesity, low back pain, and dirdnished functional status[J]. J Bone Joint Surg Am, 2011, 93(7):662- 670.
  • 4Freemont AJ. The edlular pathobiology of the degenerate intervertebral disc and discogenic back pain[J]. Rheumatology(Oxford), 2009, 48(1) :5-10.
  • 5Negrini S, Zaina F. The chimera of low back pain etiology: a dinical rehabilitation perspective[J]. Am J Phys Med Rehabil, 2013, 92(1):93-97.
  • 6Carda V, Nebbioso A, Altucd L Sirtuins and disea :the mad ahead[J]. Front Pharmacol, 2012, 3:4.
  • 7Boos N, Weissbach S, Rohrbaeh H, et al. Classification of age-related changes in lumbar intervertebral discs :3102 Volvo Award in basic scienc[J]. Spine(Phila Pa 1976), 2002, 27(23):2631-2644.
  • 81V ller JA, Schmatz C, Schultz AB. Lumbar disc degeneration: eorrdation with age, sex, and spine level in 600 autopsy specimens[J]. Spine(Phila Pa 1976), 1988, 13(2):173-178.
  • 9Anisimov SV. Cell therapy in treating agerdated intervertebral disc pathology [J]. Adv Gemntol, 2012, 25(1).105-111.
  • 10Eissenberg JC. Telomeres, cancer and aging: live long and prosper? [J]. Mo Med, 2013, 110(1):11-16.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部